The new company, Ajinomoto Althea Inc., will focus on GMP-compliant production of biopharmaceuticals based on the Corynebacterium glutamicum expression system developed by Ajinomoto
Althea news release, December 11, 2015
Ajinomoto collaborates with Althea Inc. on custom-production of biopharmaceuticals using Ajinomotos Corynex system